ScholarIQanswers from OpenAlex & ORCID
Ben Creelan
ResearcherPublications, citations & collaboration network
Ben Creelan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ben Creelan have?
ScholarIQindexed works
Ben Creelan has 187 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ben Creelan have?
ScholarIQcitation count
Ben Creelan has 7,962 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ben Creelan?
ScholarIQh-index
Ben Creelan has an h-index of 32 in OpenAlex.
What is the i10-index of Ben Creelan?
ScholarIQi10-index
Ben Creelan has an i10-index of 60 in OpenAlex.
What is the ORCID of Ben Creelan?
ScholarIQorcid
The ORCID for Ben Creelan is on the source record.
What is the OpenAlex record for Ben Creelan?
ScholarIQopenalex
The OpenAlex for Ben Creelan is on the source record.
What are the most-cited papers on Ben Creelan?
ScholarIQmost cited works
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
David P. Carbone, Martin Reck, Luis Paz‐Ares, Ben Creelan, Leora Horn, Martin Steins, Enriqueta Felip, Michel M. van den Heuvel, Tudor–Eliade Ciuleanu, Firas Badin, Neal Ready, T. Jeroen N. Hiltermann, Suresh Nair, Rosalyn A. Juergens, Solange Peters, Elisa Minenza, John Wrangle, Delvys Rodríguez‐Abreu, Hossein Borghaei, George R. Blumenschein, Liza C. Villaruz, Libor Havel, Jana Krejčí, Jesus Corral Jaime, Han Chang, William J. Geese, Prabhu Bhagavatheeswaran, Allen C. Chen, Mark A. Socinski
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
Matthew D. Hellmann, Tavi Nathanson, Hira Rizvi, Ben Creelan, Francisco Sánchez-Vega, Arun Ahuja, Ai Ni, Jacki B. Novik, Levi Mangarin, Mohsen Abu-Akeel, Cailian Liu, Jennifer L. Sauter, Natasha Rekhtman, Eliza Chang, Margaret K. Callahan, Jamie E. Chaft, Martin H. Voss, Megan Tenet, Xuemei Li, Kelly L. Covello, Andrea Renninger, Patrik Vitazka, William J. Geese, Hossein Borghaei, Charles M. Rudin, Scott Antonia, Charles Swanton, Jeff Hammerbacher, Taha Merghoub, Nicholas McGranahan, Alexandra Snyder, Jedd D. Wolchok
Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma
Matthew B. Schabath, E A Welsh, William J. Fulp, Lieping Chen, Jamie K. Teer, Zachary Thompson, Brienne E. Engel, Min Xie, Anders Berglund, Ben Creelan, S. Antonia, Jhanelle E. Gray, Steven A. Eschrich, D-T Chen, W. Douglas Cress, Eric B. Haura, Amer A. Beg
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Ben Creelan, Chao Wang, Jamie K. Teer, Eric M. Toloza, Jiqiang Yao, Sungjune Kim, Ana Marie Landin, John E. Mullinax, James J. Saller, Andreas Saltos, David Noyes, Leighann B. Montoya, Wesley Curry, Shari Pilon‐Thomas, Alberto Chiappori, Tawee Tanvetyanon, Frederic J. Kaye, Zachary Thompson, Sean Yoder, Bin Fang, John M. Koomen, Amod A. Sarnaik, Dung‐Tsa Chen, José R. Conejo-García, Eric B. Haura, Scott Antonia
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153
David Waterhouse, Edward B. Garon, Jason C. Chandler, Michael McCleod, Maen Hussein, Robert M. Jotte, Leora Horn, Davey B. Daniel, George P. Keogh, Ben Creelan, Lawrence H. Einhorn, Justin Baker, Samer S. Kasbari, Petros Nikolinakos, Sunil Babu, Félix Couture, Natasha B. Leighl, Craig H. Reynolds, George R. Blumenschein, Vijay Gunuganti, Ang Li, Nivedita Aanur, David R. Spigel